EFTUD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.295000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.785400E-01
Normal-vs-Stage2
7.731600E-01
Normal-vs-Stage3
2.313000E-01
Normal-vs-Stage4
5.279200E-01
Stage1-vs-Stage2
7.664600E-01
Stage1-vs-Stage3
1.167820E-01
Stage1-vs-Stage4
4.718400E-01
Stage2-vs-Stage3
1.143850E-01
Stage2-vs-Stage4
6.885000E-01
Stage3-vs-Stage4
1.441760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.503800E-01
Normal-vs-AfricanAmerican
5.872600E-01
Normal-vs-Asian
5.508000E-01
Caucasian-vs-AfricanAmerican
6.286000E-01
Caucasian-vs-Asian
6.792400E-01
AfricanAmerican-vs-Asian
9.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.308400E-01
Normal-vs-Female
8.574000E-01
Male-vs-Female
8.719600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.492600E-01
Normal-vs-Age(41-60Yrs)
6.147400E-01
Normal-vs-Age(61-80Yrs)
9.972200E-01
Normal-vs-Age(81-100Yrs)
5.723800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.535600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.088600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.746000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.475600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.893800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.185000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.101600E-01
Normal-vs-Daily Drinker
8.580800E-01
Normal-vs-Weekly Drinker
7.572400E-01
Normal-vs-Occasional Drinker
8.333600E-01
Normal-vs-Social Drinker
8.483000E-01
Non Drinker-vs-Daily Drinker
1.673990E-01
Non Drinker-vs-Weekly Drinker
1.376030E-01
Non Drinker-vs-Occasional Drinker
5.364200E-01
Non Drinker-vs-Social Drinker
5.241600E-01
Daily Drinker-vs-Weekly Drinker
8.775600E-01
Daily Drinker-vs-Occasional Drinker
4.657200E-01
Daily Drinker-vs-Social Drinker
5.128000E-01
Weekly Drinker-vs-Occasional Drinker
4.099800E-01
Weekly Drinker-vs-Social Drinker
4.344200E-01
Occasional Drinker-vs-Social Drinker
9.491600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.102800E-01
Normal-vs-Grade 2
4.695000E-01
Normal-vs-Grade 3
3.424400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.263380E-01
Grade 1-vs-Grade 3
1.998070E-02
Grade 1-vs-Grade 4
9.102800E-01
Grade 2-vs-Grade 3
2.380800E-01
Grade 2-vs-Grade 4
4.695000E-01
Grade 3-vs-Grade 4
3.424400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.497400E-01
Normal-vs-NonDiabetic
7.880000E-01
Diabetic-vs-NonDiabetic
3.016600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.701420E-01
Normal-vs-NoPancreatitis
8.757600E-01
Pancreatitis-vs-NoPancreatitis
1.658590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.892800E-01
Normal-vs-N1
8.021000E-01
N0-vs-N1
9.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.013600E-02
Normal-vs-TP53-NonMutant
4.880800E-01
TP53-Mutant-vs-TP53-NonMutant
1.879030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
